GlassScriptPhysician profile
Zongming Eric Chen
NPI 1043351810
$8,458.68
in general payments reported to CMS, 2019-2025
5 companies · $7,143 in 2025
The $7,143 reported for 2025 was more than what 88% of Anatomic Pathology providers received nationally (typical 2025 total: $110).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $65.00 · 2023: $1,220 · 2024: $31.13 · 2025: $7,143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,637 · Travel and Lodging: $618 · Food and Beverage: $139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,637.00 |
| Travel and Lodging | $618.08 |
| Food and Beverage | $138.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma Global Development | $7,142.50 | 2025 | Vyloy |
| Novartis Pharmaceuticals Corporation | $1,150.00 | 2023 | |
| Astellas Pharma US INC | $70.05 | 2023 | |
| Seagen INC. | $65.00 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $31.13 | 2024 | Enhertu |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zongming Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.